Clinical Trials Browser

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04771130 2026-03-04

A Study of BGB-11417 in Participants With Myeloid Malignancies

Phase 1/2 Recruiting

260 enrolled

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Myelodysplastic-Myeloproliferative Diseases

NCT06541067 2026-01-26

POSALLO

Phase 2 Recruiting

30 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT03828773 2025-12-09

PTX3AML

Phase NA Recruiting

410 enrolled

Other hematologic neoplasm

Aspergillosis, Candidiasis, Mycoses, Leukemia, Myeloid, Acute, Genetic Predisposition to Disease

NCT07185503 2025-09-22

Liposomal Amphotericin B Plus Posaconazole/Isavuconazole for Mucormycosis in Hematologic Malignancies: Efficacy and Safety

Recruiting

60 enrolled

Other hematologic neoplasm

Mucormycosis, Hematologic Neoplasms

NCT02203773 2023-05-16

Study of ABT-199 (GDC-0199) in Combination With Azacitidine or Decitabine (Chemo Combo) in Subjects With Acute Myelogenous Leukemia (AML)

Phase 1 Terminated

212 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Leukemia, Myeloid, Acute

NCT03796533 2022-02-24

Posa-Pk

Phase NA Unknown

120 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT02358499 2020-12-22

Genetic Variation and Variability in Posaconazole Pharmacokinetics in Children

Phase 1 Completed

31 enrolled

Other hematologic neoplasm

Bone Marrow Failure Disorders, Leukemia, Mycoses

NCT02875743 2020-04-02

King's Invasive Aspergillosis Study II

Phase 4 Completed

120 enrolled

Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Aplastic, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT03760445 2020-01-09

HDM201 Added to CT in R/R or Newly Diagnosed AML

Phase 1/2 Withdrawn

Other hematologic neoplasm

Leukemia, Myeloid, Acute, Neoplasm, Residual

NCT01200355 2018-05-07

Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia or Myelodysplastic Syndrome

Phase 4 Completed

113 enrolled 12 charts

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT03036046 2018-02-15

SAFEGUARDFP

Phase 1/2 Withdrawn

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00686543 2017-04-07

Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115)

Phase 4 Completed

75 enrolled 14 charts

Other hematologic neoplasm

Mycoses, Neutropenia, Leukemia, Myeloid, Acute

NCT00750737 2016-09-29

Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC)

Phase 3 Completed

46 enrolled 6 charts

Other hematologic neoplasm

Invasive Fungal Infections, Hematologic Neoplasms

Clinical Trials

MOMENTUM

A Study of BGB-11417 in Participants With Myeloid Malignancies

POSALLO

PTX3AML

Liposomal Amphotericin B Plus Posaconazole/Isavuconazole for Mucormycosis in Hematologic Malignancies: Efficacy and Safety

Study of ABT-199 (GDC-0199) in Combination With Azacitidine or Decitabine (Chemo Combo) in Subjects With Acute Myelogenous Leukemia (AML)

Posa-Pk

Genetic Variation and Variability in Posaconazole Pharmacokinetics in Children

King's Invasive Aspergillosis Study II

HDM201 Added to CT in R/R or Newly Diagnosed AML

Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia or Myelodysplastic Syndrome

SAFEGUARDFP

Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115)

Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC)